Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Andrew Last, David Weber

Premium

Affymetrix has appointed Andrew Last to the position of chief operating officer, and named David Weber as its chief commercial officer, the company said in a recent US Securities and Exchange Commission filing.

Last had been executive vice president of Affymetrix's Genetic Analysis business unit, while Weber's previous title was executive vice president of global commercial operations. The company said the organizational changes will enable its CEO Frank Witney to "focus more time on refining the strategic vision and product portfolio of the company as its business continues to diversify and the underlying technologies evolve."

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.